Click to go to DrugInjuryLaw Home

Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation

Free Case Evaluation

Drospirenone (DRSP) Birth Control Pills: 
YAZ / Yasmin / Beyaz / Safyral / Ocella / Gianvi  

Visit Our New Site >> Drug Side Effects: Legal & Medical Information

What are YAZ, Yasmin, Beyaz, Safyral, Ocella, and Gianvi?

YAZ, Yasmin, Beyaz, Safyral, Ocella, and Gianvi are birth control pills, or oral contraceptives, to contain the progestin drospirenone (DRSP).

Each of these birth control pills contain ethinyl estradiol (EE) and the progestin drospirenone (DRSP). These DRSP oral contraceptives have also been associated with several different adverse side effects such as:

  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Stroke
  • Cerebrovascular Accidents (CVA)
  • Heart Attack
  • Myocardial Infarction
  • Death


YAZ, Yasmin, Beyaz, and Safyral are manufactured by Bayer HealthCare Pharmaceuticals, Inc. Yasmin was originally made by Berlex Laboratories, which was acquired by Bayer in 2006.

Ocella is a generic version of Yasmin.  Gianvi is a generic version of YAZ.  The Ocella and Gianvi birth control pills are from Teva Pharmaceuticals and Barr Laboratories.


Ten Most Recent DRSP Birth Control Pills Case Evaluations

Ocella - Deep Vein Thrombosis (DVT) - 37 yr old woman (8042)

YAZ - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) causing Death - 42 yr old woman (8029)

Beyaz - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 16 yr old girl (8016)

Gianvi - Pulmonary Embolism (PE) - 25 yr old woman (7999)

Beyaz - Stroke (CVA) - 48 yr old woman (7997)

Safyral - Pulmonary Embolism (PE) - 39 yr old woman (7988)

Ocella - Pulmonary Embolism (PE) - 23 yr old woman (7984)

Ocella - Deep Vein Thrombosis (DVT) - 31 yr old woman (7940)

Gianvi - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 28 yr old woman (7900)

Gianvi - Deep Vein Thrombosis (DVT) - 28 yr old woman (7893)


Free Case Evaluation:  YAZ / Yasmin / Beyaz / Safyral / Ocella / Gianvi

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

Drug Injury Watch: DRSP Birth Control Pills News and Commentary

During 2013 Bayer Has Had More Than 2000 YAZ / Yasmin Lawsuits For Blood Clots That Are Not Settled

September 2013 Bayer Corporate Report Shows Apparent Progress In Settlement Negotiations, But A Number Of More Serious Cases Are Still Pending

SUMMARY: From the Bayer Stockholders’ Newsletter, Financial Report as of September 30, 2013, Third quarter of 2013:

As of October 18, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 7,660 claimants in the U.S. for a total amount of about US$1.575 billion. Bayer has only been settling claims in the U.S.for venous clot injuries (deep vein thrombosis or pulmonary embolism).... Such injuries are alleged by about 2,300 of the pending unsettled claimants. Bayer will continue to consider the option of settling such individual lawsuits in the U.S. on a case-by-case basis.

It remains to be seen whether there will be any court trials for YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral lawsuits involving arterial clots, which can cause strokes and other serious side effects. Reportedly, thus far the lawyers for Bayer have refused to negotiate these types of cases.

[Read this article in full at original source]


Earlier DRSP Birth Control Pills articles by Tom Lamb on the Drug Injury Watch blog:

Higher Risk Of Venous Thrombosis - Blood Clot Side Effects Like DVT And PE With YAZ / Yasmin Birth Control Pills Is Confirmed By September 2013 BMJ Medical Journal Article

YAZ / Yasmin / Ocella / Gianvi Blood Clot Lawsuits That Are Not Settled Yet: Number Increases, Indicating That These Legal Claims Continue To Be Filed In 2013

Legal Claims May Be Possible In California For Gianvi, Zarah, Loryna, Syeda, And Vestura (Generic YAZ / Yasmin) Blood Clot Side Effects Due To Pikerie v. Teva Case Ruling

Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed

As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level

Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe

November 2012 Litigation And Settlement Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits

2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots

Bayer Settlements: Gianvi / Ocella / Yasmin / YAZ: July 2012 Update On Drug Injury Lawsuits Filed To Date

Medical Study Finds Link Between YAZ / Yasmin And Irritable Bowel Syndrome (IBS) Coming From Drospirenone (DRSP) Progestin

Bayer Settlements For YAZ / Yasmin Lawsuits Involving Blood Clot Side Effects Like Deep Vein Thrombosis And Pulmonary Embolism

April 2012 Yasmin / YAZ Label Change: FDA Warns About Increased Risk Of Blood Clots Possible Due To Drospirenone

YAZ / Yasmin Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012

Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills

Gianvi Legal Claims Against Drug Company Still Possible Despite Mensing Case Rule Against Generic Drug Injury Lawsuits

YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)

YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online

Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting

Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella

YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Like DVT, PE, Stroke, And Heart Attack

Women Who Used YAZ / Yasmin / Ocella Are Getting Letters From Aetna Medical Insurance Company

YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism

YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects

Yasmin / YAZ MDL: First Trial Moved From September 2011 To January 2012 Per Plaintiffs' Request

Bayer Affirms Safety Of YAZ / Yasmin And Refutes 2011 BMJ Articles About Risk Of Blood Clots

Another Rather "Odd" YAZ Label Change By Bayer: March 2011

YAZ / Yasmin / Ocella Litigation: February 2011 Update

YAZ And Yasmin MDL: First Trial In Federal Court Set By Judge Herndon To Start September 2011

August 2010 Status Update For The Yaz / Yasmin / Ocella Federal Court MDL Litigation

Is Bayer Warning Or Attacking With Its New YAZ / Yasmin Package Insert, Or Label, In The U.S

March 2010: Bayer Says It Will Update Yasmin Label In Europe To Add Results From Four Medical Studies

YAZ, Yasmin, Ocella: 1,100 Lawsuits Filed As Of Mid-February 2010, According To Bayer

Medical Journal Report: Adverse Drug Reactions And Pulmonary Embolism Are Often Difficult For Doctors To Diagnose

November 2009 Medical Journal Article Describes Large Ongoing Study About Safety Of YAZ

Yasmin And Yaz Birth Control Pills Are Under Scrutiny By Drug Regulators In Europe

Waiting For The Results From Swissmedic Safety Analysis Of Yaz And Other Drospirenone-Containing Contraceptives

October 2009: Yasmin And Yaz Multidistrict Litigation (MDL) Transfer Order For Injury And Death Cases Filed In Federal Court

Some Of The Drospirenone (DRSP) Progestin Used In Yaz And Yasmin Pills May Have Been Of Bad Quality

YAZ And Yasmin May Have Higher Risk Of Venous Thrombosis Than Older Birth Control Pills

A Theory Of How Yasmin Or YAZ Might Cause Pulmonary Embolism (PE) And Other Blood Clot Related Side Effects

WebMD List Of Symptoms For Serious Side Effects From Using Estrogen-Progestin Birth Control Methods

Yasmin / YAZ Multidistrict Litigation (MDL) Motion Filed In Late July 2009

Have Yasmin-Related Blood Clot Side Effect Cases Flown Below Radar In US?

Birth Control Pill YAZ Is Subject Of Ongoing Safety Study Regarding Cardiovascular Side Effects

Yaz Birth Control Investigation

Nightline from ABC News (video)


Drug Injury Law: Legal News and Information

Gianvi (Generic YAZ), Beyaz, And Safyral Causing Blood Clots In Lung (PE) Or Legs (DVT) Are Cases That Can Get Settlements

While the YAZ / Yasmin / Ocella birth control pill lawsuits against Bayer have received more attention in the past few years, it is important to know that Gianvi, Beyaz, and Safyral cases involving blood clots can get settlments, too.

YAZ / Yasmin / Ocella / Gianvi / Beyaz / Safyral: Serious Side-Effects Lawsuit News And Information Hub

This is an up-to-date collection of drug injury lawyer blog posts and selected news articles regarding legal claims involving YAZ / Yasmin / Ocella / Gianvi / Beyaz / Safyral birth control pills.

Medical Studies Reveal Increased Risk of Blood Clots for Women Using YAZ, Yasmin, Beyaz, Safyral, Ocella, and Gianvi

Recent medical journal articles and the FDA have warned women about the potential dangers of contraceptive pills containing drospirenone (DRSP): YAZ, Yasmin, Beyaz, Safyral, Ocella, and Gianvi.

Bayer May Have Misled Women About Health Risks Of Their Popular Yasmin And YAZ Birth Control Pills

As of November 2011 over 10,000 lawsuits filed concerning YAZ / Yasmin side effects such as pulmonary embolism (PE), deep vein thrombosis (DVT), and gallbladder removal, with more cases being investigated by our law firm and other lawyers.

The YAZ Label Change In March 2011 Seems Rather "Generic" In Nature

There is nothing specific about YAZ in the new warning language added to the YAZ label in March 2011; rather, these new warnings about blood clots and pancreatitis seem to pertain to ALL combined oral contraceptives (COCs), or birth control pills.

YAZ / Yasmin / Ocella MDL Update October 2010: Bellwether, or Early Trial, Cases Set To Begin In September 2011 Per Judge Herndon Order

More than 3700 lawsuits filed to date: 41% are venous thromboembolisms (VTE), including pulmonary embolisms (PE) and deep vein thrombosis (DVT); 43% are gallbladder injuries; 10% are strokes and heart attacks / myocardial infarctions (MI).

More Than 2600 Yaz / Yasmin / Ocella Lawsuits Have Been Filed As Of August 2010

This August 2010 MDL lawsuit number does not include the Yaz / Yasmin / Ocella personal injury and wrongful death lawsuits that have been filed in the New Jersey state court "mass tort" consolidation (426 cases as of August 12, 2010) nor the Yaz / Yasmin / Ocella cases that have been filed in the Pennsylvania state court system.

March 2010: YAZ / Yasmin / Ocella Litigation Update: More Than 1,100 Lawsuits Filed To Date

These drospirenone (DRSP) containing contraceptives are associated with several serious side effects like blood clots, stroke, and heart attack, as well as lesser known side effects such as gallbladder disease and pancreatitis.  With the number of lawsuits growing, most injury and death cases are being filed in the federal MDL.

Ocella, Yasmin, YAZ, Gianvi, Beyaz, And Safyral Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack

Some medical journal articles are linking certain oral contraceptives such as Ocella, Yasmin, and Safyral as well as YAZ, Beyaz, and Gianvi to pulmonary embolism (PE) and deep vein thrombosis (DVT). These birth control pills each contain drospirenone (DRSP), a unique progestin which causes an increased risk of thromboembolism, or blood clot, side effects when compared to older oral contraceptives (OCs). Estrogen and DRSP create a potentially life-threatening combination due to their coagulative effects.

Yasmin And YAZ MDL (Multidistrict Litigation) Assigned To Judge David R. Herndon, Southern District of Illinois

On October 1, 2009 the United States Judicial Panel on Multidistrict Litigation (JPML) issued a Transfer Order which creates MDL No. 2100. This means that all YAZ and Yasmin personal injury and wrongful death cases filed in the federal court system will be consolidated into a Multidistrict Litigation, or MDL, with U.S. District Court Judge David R. Herndon presiding over these YAZ and Yasmin cases.

In 2009 Bayer Was Required To Correct Advertising Information About Benefits And Risks Of Its YAZ Birth Control Pill

In 2009 Bayer was required to run a $20 million advertising campaign to correct previous YAZ advertisements that overstated the benefits and understated the risks of this popular birth control pill after getting an FDA warning letter. Back in 2003, the FDA sent a similar warning letter about misleading ads for Yasmin.

How And Why YAZ, Yasmin, Ocella, Gianvi, Beyaz, And Safyral Pills Might Cause A Higher Rate Of Blood Clots In Women

All hormonal birth control options are associated with some health risks. However, the oral contraceptive pills YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral have the distinction of being associated with a possible higher rate of blood clots which can cause serious side effects – namely, stroke, heart attack, pulmonary embolism, and deep vein thrombosis. The obvious questions are “How?” and “Why?”.

Are The Current Warnings About Blood Clot Side Effects Associated With YAZ, Yasmin, Ocella, Gianvi, Beyaz, And Safyral Sufficient?
Although the package inserts for YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral carry a bolded warning for the increased risk of hyperkalemia associated with these birth control pills, any warnings for the associated blood clot risks are found in only regular print. Now lawsuits are being filed on behalf of women who used these birth control pills alleging there has been a failure to warn about the increased risk of blood clots.

Birth Control Pill YAZ Being Reviewed For Increased Risk Of Blood Clots And Serious Side Effects
YAZ is an oral contraceptive, or birth control pill, which combines the new "fourth generation" progestin drospirenone (DRSP) and ethinyl estradiol. YAZ has been associated with several dangerous side effects such as deep vein thrombosis (DVT), pulmonary embolism (PE), heart attacks, and strokes.

Blood Clot Side Effects Have Long Been A Safety Issue For Yasmin As Well As Its Generic Version, Ocella
Soon after the Yasmin birth control pill was approved in 2000 there were reports of pulmonary embolism (PE) and deep vein thrombosis (DVT). As a result in 2002 general practitioners in The Netherlands were warned against prescribing Yasmin over the well-known second generation birth control pills.

Pulmonary Embolism And Deep Vein Thrombosis: Symptoms, Treatment, and Recovery

For women who are using estrogen-progestin methods of birth control -- such as YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral -- here is some important information about symptoms, treatment and recovery from a blood clot, which is a serious, potentially fatal side effect of these birth control products.

YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral Class Actions
We believe that people who suffered a serious injury or death due to the YAZ, Yasmin, Ocella, Gianvi, Beyaz, or Safyral oral contraceptive pills are better served when an individual lawsuit is filed on their behalf. A serious injury or death case should not be filed as part of any YAZ, Yasmin, Ocella, Gianvi, Beyaz, or Safyral class actions together with the claims of many other people who may have had different injuries caused by these birth control pills.

Legal Compensation for YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral Injuries
If you experienced serious side effects from the use of YAZ, Yasmin, Ocella, Gianvi, Beyaz, or Safyral, or a person died due to an adverse reaction while taking these birth control pills containing drospirenone (DRSP), you may have a claim for legal compensation. Such claims involving a serious injury or death caused by the use of YAZ, Yasmin, Ocella, Gianvi, Beyaz, or Safyral are made by filing a lawsuit in court. All states have statutes of limitations that determine the deadlines by which to file lawsuits involving these drospirenone (DRSP) oral contraceptives.

All content by attorney Tom Lamb

  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535